Clinton Group Inc. Cuts Position in Humana Inc (HUM)

Clinton Group Inc. reduced its stake in shares of Humana Inc (NYSE:HUM) by 28.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,149 shares of the insurance provider’s stock after selling 7,176 shares during the period. Humana accounts for about 0.8% of Clinton Group Inc.’s holdings, making the stock its 15th biggest position. Clinton Group Inc.’s holdings in Humana were worth $5,402,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently modified their holdings of the company. MetLife Investment Advisors LLC acquired a new position in shares of Humana during the 4th quarter worth approximately $10,965,000. AMP Capital Investors Ltd raised its position in shares of Humana by 2.5% during the 4th quarter. AMP Capital Investors Ltd now owns 105,243 shares of the insurance provider’s stock worth $26,108,000 after purchasing an additional 2,532 shares during the last quarter. Iguana Healthcare Management LLC acquired a new position in shares of Humana during the 4th quarter worth approximately $5,582,000. Koch Industries Inc. acquired a new position in shares of Humana during the 4th quarter worth approximately $441,000. Finally, Banco de Sabadell S.A acquired a new position in shares of Humana during the 4th quarter worth approximately $7,075,000. Hedge funds and other institutional investors own 93.34% of the company’s stock.

HUM has been the subject of several research reports. Zacks Investment Research downgraded Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, March 13th. ValuEngine upgraded Humana from a “hold” rating to a “buy” rating in a report on Monday, April 2nd. Piper Jaffray Companies reiterated a “buy” rating and issued a $313.00 price target on shares of Humana in a report on Wednesday, April 4th. Argus boosted their price target on Humana from $270.00 to $330.00 and gave the company a “buy” rating in a report on Monday, April 16th. Finally, Cantor Fitzgerald reiterated a “hold” rating and issued a $250.00 price target on shares of Humana in a report on Monday, April 23rd. Seven research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $288.89.

Shares of HUM stock traded up $2.82 on Friday, reaching $308.98. 17,015 shares of the stock were exchanged, compared to its average volume of 523,789. The company has a market cap of $41.42 billion, a price-to-earnings ratio of 26.27, a PEG ratio of 1.56 and a beta of 0.95. The company has a quick ratio of 1.55, a current ratio of 1.55 and a debt-to-equity ratio of 0.47. Humana Inc has a 1-year low of $229.84 and a 1-year high of $309.18.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, May 2nd. The insurance provider reported $3.36 EPS for the quarter, topping analysts’ consensus estimates of $3.21 by $0.15. The business had revenue of $14.28 billion during the quarter, compared to the consensus estimate of $14.22 billion. Humana had a return on equity of 16.74% and a net margin of 3.36%. During the same period in the prior year, the firm posted $2.75 EPS. analysts expect that Humana Inc will post 13.99 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 27th. Stockholders of record on Friday, June 29th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, June 28th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.65%. Humana’s payout ratio is 17.08%.

In other news, insider Timothy Alan Wheatley sold 11,468 shares of the company’s stock in a transaction on Tuesday, June 19th. The stock was sold at an average price of $299.40, for a total transaction of $3,433,519.20. Following the completion of the sale, the insider now directly owns 3,889 shares in the company, valued at approximately $1,164,366.60. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Jody L. Bilney sold 27,461 shares of the company’s stock in a transaction on Friday, June 15th. The stock was sold at an average price of $306.46, for a total value of $8,415,698.06. Following the sale, the insider now owns 11,467 shares of the company’s stock, valued at $3,514,176.82. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 124,009 shares of company stock valued at $36,887,143. Insiders own 0.60% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply